A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis




TekijätButcher Steele C, Vos Jaqueline L, Fortuni Federico, Galloo Xavier, Liem Sophie IE, Bax Jeroen J, Delgado Victoria, Vonk Madelon C, van Leuven Sander I, Snoeren Miranda, El Messaoudi Saloua, de Vries-Bouwstra Jeska K, Nijveldt Robin, Marsan Nina Ajmone

KustantajaOxford Univ Press

Julkaisuvuosi2023

JournalRheumatology

Tietokannassa oleva lehden nimiRHEUMATOLOGY

Lehden akronyymiRHEUMATOLOGY

Vuosikerta62

NumeroS1

AloitussivuS120

LopetussivuS131

Sivujen määrä12

ISSN1462-0324

eISSN1462-0332

DOIhttps://doi.org/10.1093/rheumatology/keac256

Verkko-osoitehttps://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/keac256/6575497

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/175907618


Tiivistelmä

Objective

This study aimed to determine whether lower values of feature-tracking cardiovascular magnetic resonance (CMR)-derived left atrial reservoir strain (LARS) and impaired left ventricular (LV) global longitudinal strain (GLS) were associated with the presence of symptoms and long-term prognosis in patients with SSc.

Methods

A total of 100 patients {54 [interquartile range (IQR) 46-64] years, 42% male} with SSc who underwent CMR imaging at two tertiary referral centres were included. All patients underwent analysis of LARS and LV GLS using feature-tracking on CMR and were followed-up for the occurrence of all-cause mortality.

Results

The median LV GLS was -21.8% and the median LARS was 36%. On multivariable logistic regression, LARS [odds ratio (OR) 0.964 per %, 95% CI 0.929, 0.998, P = 0.049] was independently associated with New York Heart Association (NYHA) class II-IV heart failure symptoms. Over a median follow-up of 37 (21-62) months, a total of 24 (24%) patients died. Univariable Cox regression analysis demonstrated that LARS [hazard ratio (HR) 0.94 per 1%, 95% CI 0.91, 0.97, P < 0.0001) and LV GLS (HR 1.10 per %, 95% CI 1.03, 1.17, P = 0.005) were associated with all-cause mortality, while LV ejection fraction was not. Likelihood ratio tests demonstrated that LARS provided incremental value over prognostically important clinical and imaging parameters, including late gadolinium enhancement.

Conclusion

In patients with SSc, LARS was independently associated with the presence of NYHA class II-IV heart failure symptoms. Although both LARS and LV GLS were associated with all-cause mortality, only LARS provided incremental value over all evaluated variables known to be prognostically important in patients with SSc.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 22:57